Oxford Finance Provides $100MM Loan Facility to Pliant Therapeutics
Pliant Therapeutics, a clinical stage biotechnology company, entered into a loan facility agreement with Oxford Finance for up to $100 million of non-dilutive financing.
May 6, 2022
Keith Cummings | Oxford Finance | Pliant Therapeutics
Ian Koplin